Settlement over Amgen $28bn acquisition shows the antitrust chief still won concessions to protect consumers
Mergers & Acquisitions
Settlement over Amgen $28bn acquisition shows the antitrust chief still won concessions to protect consumers
Mergers & Acquisitions